P01584 (IL1B_HUMAN) Homo sapiens (Human)

Interleukin-1 beta UniProtKBInterProSTRINGInteractive Modelling

269 aa; Sequence (Fasta)

Available Structures

62 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
TYPE-1 INTERLEUKIN-1 RECEPTOR COMPLEXED WITH INTERLEUKIN-1 BETA
1itb
 Heteromer
P14778; 		117-269
Assess
Solution structure of a scFv-IL-1B complex
2kh2
 Heteromer
117-269
Assess
Crystal structure of EBI-005, a chimera of human IL-1beta and IL-1Ra, bound to human Interleukin-1 …
4gaf
 Heteromer
P14778; 		117-268
4×NAG; 1×NA;
Assess
Crystal structure of an Interleukin-1 receptor complex
3o4o
 Heteromer
P27930; Q9NPH3; 		117-268
2×NAG; 4×NAG;
Assess
The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody ne…
5bvp
 Heteromer
119-269
2×CL;
Assess
Crystal Structure Of Human Il-1beta In Complex With Antibody Binding Fragment Of IgG26A
7chz
 Heteromer
118-268
Assess
Structure of the IL-1b signaling complex
4dep
 Heteromer
P14778; Q9NPH3; 		117-267
7×NAG;
Assess
AAL160 FAB IN COMPLEX WITH HUMAN INTERLEUKIN-1 BETA
7z4t
 Heteromer
119-269
Assess
Crystal structure of human IL-1beta in complex with therapeutic antibody binding fragment of gevoki…
4g6m
 Heteromer
118-267
Assess
Fab 4AB007 bound to Interleukin-1-beta
5mvz
 Heteromer
119-268
4×GOL;
Assess
Crystal Structure Of Human Il-1beta In Complex With Antibody Binding Fragment Of IgG26
7chy
 Heteromer
119-268
Assess
Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of ca…
4g6j
 Heteromer
120-268
Assess
Interleukin-1-beta LBT L3 Mutant
3pok
monomer117-269
Assess
CRYSTALLOGRAPHIC REFINEMENT OF INTERLEUKIN-1 BETA AT 2.0 ANGSTROMS RESOLUTION
2i1b
monomer117-269
Assess
Interleukin 1B Mutant F146W
1too
monomer117-269
Assess
INTERLEUKIN 1 BETA MUTANT F101Y
1twe
monomer117-269
Assess
Interleukin 1 beta F101W
1t4q
monomer117-269
Assess
Triple mutation in interleukin 1 beta cavity:replacement of phenylalanines with tryptophan.
1tp0
monomer117-269
Assess
Interleukin-1 Beta Mutant F146Y
1twm
monomer117-269
Assess
HUMAN INTERLEUKIN-1 BETA
9ilb
monomer117-269
Assess
Interleukin 1 beta mutant F42W
1s0l
monomer117-269
Assess
HIGH-RESOLUTION THREE-DIMENSIONAL STRUCTURE OF INTERLEUKIN-1 BETA IN SOLUTION BY THREE-AND FOUR-DIM…
7i1b
monomer117-269
Assess
HIGH-RESOLUTION THREE-DIMENSIONAL STRUCTURE OF INTERLEUKIN-1 BETA IN SOLUTION BY THREE-AND FOUR-DIM…
6i1b
monomer117-269
Assess
INTERLEUKIN-1 BETA FROM JOINT X-RAY AND NMR REFINEMENT
1iob
monomer117-269
Assess
Human IL-1beta, unliganded
8rys
monomer118-269
1×SO4;
Assess
PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z2643472210 in complex with INTERLE…
5r8q
monomer117-268
2×SO4; 1×JGY;
Assess
PanDDA analysis group deposition of ground-state model of INTERLEUKIN-1 BETA
5r7w
monomer117-268
2×SO4;
Assess
PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z57475877 in complex with INTERLEUK…
5r8e
monomer117-268
2×SO4; 1×S7S;
Assess
PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z1818332938 in complex with INTERLE…
5r8m
monomer117-268
2×SO4; 1×S8G;
Assess
PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z2377835233 in complex with INTERLE…
5r8f
monomer117-268
2×SO4; 1×K3Y;
Assess
PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z1881545321 in complex with INTERLE…
5r8o
monomer117-268
2×SO4; 1×S8P;
Assess
PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z1259086950 in complex with INTERLE…
5r8g
monomer117-268
2×SO4; 1×S7V;
Assess
PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z1262246195 in complex with INTERLE…
5r85
monomer117-268
2×SO4; 1×S7A;
Assess
PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z210803634 in complex with INTERLEU…
5r8i
monomer117-268
2×SO4; 1×A7N;
Assess
PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z1745658474 in complex with INTERLE…
5r8d
monomer117-268
2×SO4; 1×S7J;
Assess
PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z44592329 in complex with INTERLEUK…
5r87
monomer117-268
2×SO4; 1×K0G;
Assess
PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z1492796719 in complex with INTERLE…
5r8a
monomer117-268
2×SO4; 1×S7G;
Assess
PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z355728146 in complex with INTERLEU…
5r8k
monomer117-268
2×SO4; 1×S8D;
Assess
PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z1545313172 in complex with INTERLE…
5r88
monomer117-268
2×SO4; 1×LWA;
Assess
PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z57292400 in complex with INTERLEUK…
5r8n
monomer117-268
2×SO4; 1×S8J;
Assess
Crystal structure of EBI-005, a chimera of human IL-1beta and IL-1Ra
4gai
monomer117-268
Assess
PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z2027049478 in complex with INTERLE…
5r8b
monomer117-268
2×SO4; 2×K34;
Assess
PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z111716368 in complex with INTERLEU…
5r8h
monomer117-268
2×SO4; 1×T91;
Assess
PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z943693514 in complex with INTERLEU…
5r86
monomer117-268
2×SO4; 1×GT4;
Assess
Determination of Solvent Content in Cavities in Interleukin-1 Using Experimentally-Phased Electron …
2nvh
monomer117-268
2×SO4;
Assess
PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z818727262 in complex with INTERLEU…
5r8p
monomer117-268
2×SO4; 1×S8V;
Assess
PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z30857828 in complex with INTERLEUK…
5r8c
monomer117-268
2×SO4; 1×M25;
Assess
PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z1891773393 in complex with INTERLE…
5r8l
monomer117-268
2×SO4; 1×NY4;
Assess
PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z355728146 in complex with INTERLEU…
5r8j
monomer117-268
2×SO4; 1×S8D;
Assess
PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z217038356 in complex with INTERLEU…
5r89
monomer117-268
2×SO4; 1×S7D;
Assess
Crystal Structure of human IL-1beta in complex with a low molecular weight antagonist
8c3u
monomer117-268
1×T9C;
Assess
INTERLEUKIN-1 BETA (IL-1 BETA) (MUTANT WITH CYS 71 REPLACED BY ALA) (C71A)
21bi
monomer119-269
Assess
CRYSTAL STRUCTURE OF RECOMBINANT HUMAN INTERLEUKIN-1BETA AT 2.0 ANGSTROMS RESOLUTION
1i1b
monomer119-269
Assess
FUNCTIONAL IMPLICATIONS OF INTERLEUKIN-1BETA BASED ON THE THREE-DIMENSIONAL STRUCTURE
4i1b
monomer119-269
Assess
Structure of Interleukin 1B solved by SAD using an inserted Lanthanide Binding Tag
3ltq
monomer118-268
1×TB; 2×ACT; 1×SO4;
Assess
A COMPARISON OF THE HIGH RESOLUTION STRUCTURES OF HUMAN AND MURINE INTERLEUKIN-1B
5i1b
monomer119-269
Assess
THE STRUCTURE OF AN INTERLEUKIN-1 BETA MUTANT WITH REDUCED BIOACTIVITY SHOWS MULTIPLE SUBTLE CHANGE…
1hib
monomer119-269
Assess
INTERLEUKIN-1 BETA (IL-1 BETA) (MUTANT WITH CYS 8 REPLACED BY ALA (C8A)
41bi
monomer119-269
Assess
Fragment KCL_I013 in complex with IL-1-beta
6y8i
monomer119-268
1×SO4; 1×OGE;
Assess
Fragment bikinin bound to Interleukin 1 beta
6y8m
monomer119-268
1×SO4; 2×SX2;
Assess
Crystal structure of Interleukin 1-beta F42W/W120F mutant
1l2h
monomer120-268
Assess
INTERLEUKIN-1 BETA (IL-1 BETA) (MUTANT WITH CYS 71 REPLACED BY SER) (C71S)
31bi
monomer119-267
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
1iob.1.Amonomer0.84117-269
100.00
Assess